Sernova Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SEOVF research report →
Companywww.sernova.com
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
- CEO
- Jonathan N. Rigby
- IPO
- 2007
- Employees
- 17
- HQ
- London, ON, GB
Price Chart
Valuation
- Market Cap
- $39.40M
- P/E
- -4.08
- P/S
- 0.00
- P/B
- -1.97
- EV/EBITDA
- -6.08
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 51.72%
- ROIC
- 152.36%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-15,741,351 · 51.10%
- EPS
- $-0.05 · 52.10%
- Op Income
- $-15,023,024
- FCF YoY
- 42.28%
Performance & Tape
- 52W High
- $0.16
- 52W Low
- $0.09
- 50D MA
- $0.12
- 200D MA
- $0.12
- Beta
- 0.68
- Avg Volume
- 38.63K
Get TickerSpark's AI analysis on SEOVF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SEOVF Coverage
We haven't published any research on SEOVF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SEOVF Report →